US2.ai secures US$15M Series A to automate fight against heart disease

Singapore-based medtech startup Us2.ai, which uses machine learning to automate the fight against heart disease, has raised US$15 million in a Series A round led by IHH Healthcare and Australian healthcare-focused fund Heal Partners. Lifesciences-focused Pappas Capital and existing investors joined the round, including Sequoia India, EDBI, and Partech Ventures. The firm will use the […] The post US2.ai secures US$15M Series A to automate fight against heart disease appeared first on e27.